Gary E. Deng

Integrative Medicine Specialist

Interim Chief, Integrative Medicine Service

Conditions Treated:

Gary E. Deng, MD

About Me

Many cancer patients are interested in complementary and alternative medicine. I help patients understand how some of these therapies can help while others can be counter-productive. I also counsel patients on what else they can do to help themselves before, during, and after cancer treatment, taking advantage of what integrative medicine has to offer. Integrative medicine can reduce symptoms, improve quality of life, facilitate disease prevention, and promote wellness.

Read more

I am a principal investigator of several research projects on acupuncture and botanical/herbal agents, which are funded by the National Institutes of Health. I have authored review articles and medical textbook chapters on Integrative Medicine. These include “Integrative Oncology Clinical Practice Guidelines” adopted by the Society of Integrative Oncology and American College of Chest Physicians, and “Integrative Medicine Research: Context and Priorities” commissioned by the Institute of Medicine of the National Academy of Sciences. I have a particular interest in physician education. I am also active in the professional community and serve as the current president of the Society for Integrative Oncology.

  • Clinical Expertise: Integrative Medicine
  • Languages Spoken: English
  • Education: MD, Beijing Medical University (China); PhD, University of Miami
  • Residencies: The University of Texas Medical School at Houston
  • Board Certifications: Internal Medicine

New Patient Appointments

Making an appointment

Call 800-525-2225

See My Colleagues

Read more

Pfister DG, Cassileth BR, Deng GE, et al. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol. May 20 2010; 28(15): 2565-2570

Deng G, Weber W, Sood A, Kemper KJ. Research on integrative healthcare: context and priorities. Explore (NY). May-Jun 2010; 6(3):143-158

Krasovsky J, Chang DH, Deng G, et al. Inhibition of human dendritic cell activation by hydroethanolic but not lipophilic extracts of turmeric (Curcuma longa). Planta Med. Mar 2009; 75(4): 312-315

Deng GE, Frenkel M, Cohen L, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. Journal of the Society for Integrative Oncology. Summer 2009; 7(3): 85-120

Deng G, Lin H, Seidman A, et al. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. J Cancer Res Clin Oncol. Sep 2009; 135(9): 1215-1221

Cassileth BR, Rizvi N, Deng G, et al. Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients. Cancer Chemother Pharmacol. Dec 2009; 65(1): 67-71

Deng G, Hou BL, Holodny AI, Cassileth BR. Functional magnetic resonance imaging (fMRI) changes and saliva production associated with acupuncture at LI-2 acupuncture point: a randomized controlled study. BMC Complement Altern Med. 2008;8:37

Deng G, Rusch V, Vickers A, et al. Randomized controlled trial of a special acupuncture technique for pain after thoracotomy. J Thorac Cardiovasc Surg. Dec 2008;136(6):1464-1469

Ragupathi G, Yeung KS, Leung PC, et al. Evaluation of widely consumed botanicals as immunological adjuvants. Vaccine. Sep 2 2008;26(37):4860-4865

Deng G. Integrative Cancer Care in a US Academic Cancer Centre: The Memorial Sloan Kettering Experience. Curr Oncol. Aug 2008;15 Suppl 2:s108 es168-171

Deng G, Vickers A, Yeung S, Cassileth B.. Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients.. Journal of Clinical Oncology Dec 31, 2007; 25(35) :5546-7

Deng GE, Cassileth BR, Cohen L, et al. Integrative Oncology Practice Guidelines. J Soc Integr Oncol. Spring 2007; 5(2):65-84

Vickers AJ, Feinstein MB, Deng GE, Cassileth BR. Acupuncture for dyspnea in advanced cancer: a randomized, placebo-controlled pilot trial [ISRCTN89462491]. BMC Palliat Care. Aug 18 2005;4:5

Deng G, Vickers A, Simon Yeung K, Cassileth BR. Acupuncture: integration into cancer care. Journal of the Society for Integrative Oncology. Spring 2006;4(2):86-92

Deng G, Cassileth BR. To what extent do cancer patients use complementary and alternative medicine? Nat Clin Pract Oncol. Oct 2005; 2(10): 496-497

Deng G, Cassileth BR. Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA Caner J Clin. Mar-Apr 2005: 55(2): 109-116

Deng, Cassileth BR, Yeung KS. complementary therapies for cancer-related symptoms. J Support Oncol. Sep-Oct 2004; 2(5): 491-426; discussion 427-429

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.